Clinical Trials Browser

Phase 3 × Amyloidosis × Filgrastim × Clear all

NCT01998503 2013-11-29

Bortezomib and Dexamethasone Followed by ASCT Compared With ASCT Alone in Treating Patients With AL Amyloidosis

Phase 3 Completed

Immunoglobulin Light-chain Amyloidosis, Amyloidosis